Securities code: Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) securities abbreviation: Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) Announcement No.: 2022051 bond Code: 110076 bond abbreviation: Huahai convertible bond
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521)
Notice on 2021 annual performance briefing
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Meeting time: 15:30-16:30, May 13, 2022
Venue: Panorama “investor relations interactive platform”（ http://ir.p5w.net. ）, investors can directly participate in this briefing online.
Meeting mode: network interaction mode
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) (hereinafter referred to as “the company”) was published on April 26, 2022 in China Securities Journal, Shanghai Securities News, securities times, securities daily and Shanghai Stock Exchange www.sse com. cn. The annual report of Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) 2021 and its summary were published on the website. In order to strengthen the communication with investors, the company plans to hold the company’s 2021 annual performance briefing at 15:30 on May 13, 2022 to communicate and exchange with investors on the company’s 2021 annual performance and other related matters. The relevant information is hereby announced as follows:
1、 Description meeting type
The investor briefing will be held in the form of online interaction. At that time, it will communicate and exchange with investors on the company’s 2021 annual performance and other related matters, and answer the questions generally concerned by investors within the scope of information disclosure.
2、 Explain the time and place of the meeting
Meeting time: 15:30-16:30, May 13, 2022;
Venue: Panorama “investor relations interactive platform”（ http://ir.p5w.net. ）；
Meeting mode: network interaction mode.
3、 Participants
Mr. Chen Baohua, the company’s director and President, Mr. Xin Jinguo, the company’s independent director, Mr. Zhu Yonghua, the company’s director, vice president and Secretary of the board of directors, and Ms. Zhang Mei, the company’s chief financial officer, will attend the performance presentation meeting.
4、 Investor participation mode
Investors can log in to panorama’s “investor relations interactive platform” within the above specified time（ http://ir.p5w.net. ）Communicate with the company.
The company welcomes the majority of investors to provide the problems that need to be understood and concerned to the company in advance through e-mail, telephone, fax and other forms before the briefing. The company will answer the problems generally concerned by investors at this performance briefing.
5、 Contact person and consultation method
Contact: Jin min, Wang Huiting
Tel: 057685991096; 057685015699
Email: Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) @huahaipharm.com.
Fax: 057685016010
6、 Other matters
After the performance presentation meeting is held, investors can use panorama（ https://ir.p5w.net. ）, check the specific convening and main contents of the performance description meeting.
It is hereby announced.
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) board of directors
May 4, 2022
